Brazil is a mid-developed country with one of the highest seroprevalence rates of HIV in Latin America and an increasing number of new cases in women. We at UCLA have established a new consortium of collaborators between investigators in Brazil and in the US for studies of HIV-1 transmission. We propose to participate in the scientific agenda of the HPTN as a clinical unit for international studies in Brazil for prevention of HIV perinatal and heterosexual transmission. Brazil is a unique site for performance of clinical trials because it has advanced infra structure and issues relevant to both industrialized and developing nations. We plan to conduct phase I, H, and III clinical trials addressing important issues of HIV perinatal transmission which will be based on important questions of HIV pathogenesis. Results of these studies will be applicable to Brazil, and to both industrialized and developing countries. Because of the rising incidence of HIV infection particularly in women, Brazil is highly suitable for studies of prevention of sexual transmission in HIV uninfected high- risk populations, especially through trials of treatment of sexually transmitted diseases, use of microbicides and behavioral approaches. We have established a collaboration with outstanding investigators from three sites in Brazil where populations of HW infected mothers and exposed infants and HIV negative high risk women are available for recruitment into perinatal and intervention trials. We have the capability to expand prevention trials not only to other sites within Brazil, but to additional populations similarly affected by HIV, such as adolescents (including street youth), intravenous drug users, commercial sex workers or men who have sex with men. Our laboratory facilities at UCLA and research experience, combined with outstanding research facilities and human resources at our core laboratory site in Brazil, can generate high quality immunology and virology laboratory capabilities to provide both standard and innovative assays to support the clinical trials and the HPTN scientific agenda.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI047986-03
Application #
6511478
Study Section
Special Emphasis Panel (ZAI1-KWR-A (M1))
Program Officer
Adeniyi-Jones, Samuel K
Project Start
2000-07-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
3
Fiscal Year
2002
Total Cost
$599,397
Indirect Cost
Name
University of California Los Angeles
Department
Pediatrics
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Adachi, Kristina; Xu, Jiahong; Ank, Bonnie et al. (2018) Congenital CMV and HIV Perinatal Transmission. Pediatr Infect Dis J :
Yeganeh, Nava; Watts, D Heather; Xu, Jiahong et al. (2018) Infectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants: Results From the HPTN 040/PACTG 1043 Trial. Pediatr Infect Dis J 37:1271-1278
Yeganeh, Nava; Kerin, Tara; Ank, Bonnie et al. (2018) Human Immunodeficiency Virus Antiretroviral Resistance and Transmission in Mother-Infant Pairs Enrolled in a Large Perinatal Study. Clin Infect Dis 66:1770-1777
Adachi, Kristina; Klausner, Jeffrey D; Xu, Jiahong et al. (2016) Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected Pregnant Women and Adverse Infant Outcomes. Pediatr Infect Dis J 35:894-900
Adachi, Kristina; Klausner, Jeffrey D; Bristow, Claire C et al. (2015) Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission. Sex Transm Dis 42:554-65
Yeganeh, Nava; Watts, Heather D; Camarca, Margaret et al. (2015) Syphilis in HIV-infected mothers and infants: results from the NICHD/HPTN 040 study. Pediatr Infect Dis J 34:e52-7
Nielsen-Saines, Karin; Komarow, Lauren; Cu-Uvin, Susan et al. (2012) Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics 129:e1525-32
Nielsen-Saines, Karin; Watts, D Heather; Veloso, Valdilea G et al. (2012) Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med 366:2368-79